logo

FDA Calendar

Share
Company Name Athenex, Inc.
Drug Name Oral Paclitaxel in combination with Encequidar (NDA)
Event Name FDA decision on Oral Paclitaxel in combination with Encequidar for the treatment of Metastatic Breast Cancer
Event Date 02/28/2021
Outcome Date
Outcome
Drug Status Priority Review
Rival Drugs
Market Potential
Other Approvals
News
Return to FDA Calendar